Kiromic Biopharma

Houston, United States

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.

$8.0M raised

Oct 2022

Post-IPO Equity

Bioinformatics Biopharma Biotechnology Health Care Life Science

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kiromic Biopharma

How much funding has Kiromic Biopharma raised?

Kiromic Biopharma has raised $8.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2022.

Where is Kiromic Biopharma headquartered?

Kiromic Biopharma is headquartered in Houston, United States.

What does Kiromic Biopharma do?

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.

What stage is Kiromic Biopharma at?

Kiromic Biopharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 27, 2022.

MLA

"Kiromic Biopharma — Funding & Investors." VCBacked, October 27, 2022, https://www.vcbacked.co/company/kiromic-biopharma. Accessed July 2, 2026.

APA

VCBacked. (2022). Kiromic Biopharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/kiromic-biopharma

Wikipedia (cite web)

{{cite web |title=Kiromic Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/kiromic-biopharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 27, 2022.

Similar Companies in Bioinformatics

Constantiam Biosciences